Belgium
# |
Name |
Current Liabilities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 2.89 B
|
Dec. 31, 2023 | USD 195.15 | -0.39% |
|
Belgium |
|
2 |
USD 1.04 B
|
Dec. 31, 2023 | USD 19.13 | -0.63% |
|
Belgium |
|
3 |
USD 499.56 M
|
Dec. 31, 2023 | USD 13.71 | -0.44% |
|
Belgium |
|
4 |
USD 472.65 M
|
Dec. 31, 2023 | USD 24.20 | -0.41% |
|
Belgium |
|
5 |
USD 193.44 M
|
Dec. 31, 2023 | USD 17.21 | 1.09% |
|
Belgium |
|
6 |
USD 21.49 M
|
Dec. 31, 2023 | USD 2.81 | 6.87% |
|
Belgium |
|
7 |
USD 19.52 M
|
Dec. 31, 2023 | USD 2.00 | NA |
|
Belgium |
|
8 |
USD 15.94 M
|
Dec. 31, 2023 | USD 9.32 | -0.11% |
|
Belgium |
|
9 |
USD 7.46 M
|
Dec. 31, 2023 | USD 6.22 | -0.06% |
|
Belgium |
The Pharmaceuticals company in Belgium with the highest Current Liabilities is UCB SA (Brussels Stock Exchange: UCB.BR) at USD 2.89 B.
The Pharmaceuticals company in Belgium with the lowest Current Liabilities is Hyloris Pharmaceuticals SA (Brussels Stock Exchange: HYL.BR) at USD 7.46 M.
The top 10 Pharmaceuticals companies in Belgium by Current Liabilities are UCB SA, Azelis Group NV, Ion Beam Applications SA, Galapagos NV, Fagron NV, Sequana Medical NV, MDxHealth SA, Nyxoah S.A. and Hyloris Pharmaceuticals SA.
The bottom 10 Pharmaceuticals companies in Belgium by Current Liabilities are Hyloris Pharmaceuticals SA, Nyxoah S.A., MDxHealth SA, Sequana Medical NV, Fagron NV, Galapagos NV, Ion Beam Applications SA, Azelis Group NV and UCB SA.